These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26957614)

  • 1. Outcome Assessments and Cost Avoidance of an Oral Chemotherapy Management Clinic.
    Wong SF; Bounthavong M; Nguyen CP; Chen T
    J Natl Compr Canc Netw; 2016 Mar; 14(3):279-85. PubMed ID: 26957614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
    Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
    J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation and preliminary outcomes of a comprehensive oral chemotherapy management clinic.
    Wong SF; Bounthavong M; Nguyen C; Bechtoldt K; Hernandez E
    Am J Health Syst Pharm; 2014 Jun; 71(11):960-5. PubMed ID: 24831001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
    Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM
    JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician-pharmacist collaboration for oral chemotherapy monitoring: Insights from an academic genitourinary oncology practice.
    Holle LM; Puri S; Clement JM
    J Oncol Pharm Pract; 2016 Jun; 22(3):511-6. PubMed ID: 25900102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financial impact from in-office dispensing of oral chemotherapy.
    Howard A; Kerr J; McLain M; Modlin J
    J Oncol Pharm Pract; 2019 Oct; 25(7):1570-1575. PubMed ID: 30249154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of body mass index on prescribing costs and potential cost savings of a weight management programme in primary care.
    Counterweight Project Team
    J Health Serv Res Policy; 2008 Jul; 13(3):158-66. PubMed ID: 18573765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Adherence Rates and Clinical Outcomes of an Integrated, Closed-Loop, Pharmacist-Led Oral Chemotherapy Management Program.
    Muluneh B; Schneider M; Faso A; Amerine L; Daniels R; Crisp B; Valgus J; Savage S
    J Oncol Pract; 2018 Jun; 14(6):e324-e334. PubMed ID: 29799768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction.
    Ribed A; Romero-Jiménez RM; Escudero-Vilaplana V; Iglesias-Peinado I; Herranz-Alonso A; Codina C; Sanjurjo-Sáez M
    Int J Clin Pharm; 2016 Apr; 38(2):280-8. PubMed ID: 26715547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Errors and Nonadherence in Pediatric Oral Chemotherapy Use.
    Walsh K; Ryan J; Daraiseh N; Pai A
    Oncology; 2016; 91(4):231-236. PubMed ID: 27487185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of capecitabine (Xeloda) into a cancer centre: UK experience.
    Faithfull S; Deery P
    Eur J Oncol Nurs; 2004; 8 Suppl 1():S54-62. PubMed ID: 15341882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nursing intervention to enhance outpatient chemotherapy symptom management: Patient-reported outcomes of a randomized controlled trial.
    Traeger L; McDonnell TM; McCarty CE; Greer JA; El-Jawahri A; Temel JS
    Cancer; 2015 Nov; 121(21):3905-13. PubMed ID: 26194461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-World Analysis of Medical Costs and Healthcare Resource Utilization in Elderly Women with HR+/HER2- Metastatic Breast Cancer Receiving Everolimus-Based Therapy or Chemotherapy.
    Hao Y; Li N; Fang AP; Koo V; Peeples M; Kageleiry A; Wu EQ; Guérin A
    Adv Ther; 2016 Jun; 33(6):983-97. PubMed ID: 27216253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of adverse events during treatment with everolimus plus exemestane or single-agent chemotherapy in patients with advanced breast cancer in Western Europe.
    Campone M; Yang H; Faust E; Kageleiry A; Signorovitch JE; Zhang J; Gao H
    J Med Econ; 2014 Dec; 17(12):837-45. PubMed ID: 25164472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility pilot on medication adherence and knowledge in ambulatory patients with gastrointestinal cancer.
    Sommers RM; Miller K; Berry DL
    Oncol Nurs Forum; 2012 Jul; 39(4):E373-9. PubMed ID: 22750908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer oral therapy: emerging related issues.
    Banna GL; Collovà E; Gebbia V; Lipari H; Giuffrida P; Cavallaro S; Condorelli R; Buscarino C; Tralongo P; Ferraù F
    Cancer Treat Rev; 2010 Dec; 36(8):595-605. PubMed ID: 20570443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication errors involving oral chemotherapy.
    Weingart SN; Toro J; Spencer J; Duncombe D; Gross A; Bartel S; Miransky J; Partridge A; Shulman LN; Connor M
    Cancer; 2010 May; 116(10):2455-64. PubMed ID: 20225328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEDUCATE trial: effectiveness of an intensive EDUCATional intervention for IT-mediated MEDication management in the outpatient clinic - study protocol for a cluster randomized controlled trial.
    van Stiphout F; Zwart-van Rijkom JE; Aarts JE; Koffijberg H; Klarenbeek-deJonge E; Krulder M; Roes KC; Egberts AC; ter Braak EW
    Trials; 2015 May; 16():223. PubMed ID: 25997633
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.